AZITHROMYCINE Sandoz 200 mg/5ml p susp fl 15 ml
7680576270026
CH-57627
J01FA10
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Azithromycin Sandoz, Pulver zur Herstellung einer Suspension zum Einnehmen
Pulver zur Herstellung einer Suspension zum Einnehmen
15
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
azithromycinum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
azithromycinum dihydricum
|
- | Substance | WIZUS |
|
saccharum
|
- | Substance | HBESI |
|
trinatrii phosphas anhydricus
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
xanthani gummi
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
propylenglycolum
|
- | Substance | HBESI |
|
E 220
|
- | Substance | HBESI |
|
natrium
|
0.2554 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 14.30
Specialties list
Yes
Generic
Yes
SL addition date:
01/08/2008
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57627
- Drug name
- Azithromycin Sandoz, Pulver zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- PULS
- ATC Code
- J01FA10
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 14/05/2008
- Authorization expiration date
- 19/03/2026
- IT number
- 08.01.6.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AZITHROMYCINE Sandoz 200 mg/5ml p susp fl 15 ml
- Description (DE)
- AZITHROMYCIN Sandoz 200 mg/5ml f Susp Fl 15 ml
- Market launch
- 14/05/2008
- Market withdrawal
- 19/03/2026
- Narcotic (BTM)
- No